Clinical Trial Update: A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus [Phase 1]

View source ↗

Summary

Phase 1 neoadjuvant trial assessing an immune-targeted therapy in combination with a lysogenic HSV virus for resectable head and neck squamous cell carcinoma; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Immune-targeted therapy
• Lysogenic HSV Virus

Snippet

Sponsor: West China Hospital | Conditions: HNSCC, Lysogenic HSV Virus | Phase 1 | Status: RECRUITING